Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Human Vaccines & Immunotherapeutics|September 11, 2023
The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshopHeidi Hempel, Nicholas Mantis, Christopher D Heaney, et al.
The Lancet. Microbe|January 15, 2024
The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assaysHeidi Hempel, Mark Page, Troy Kemp, et al.
Clinical Chemistry|December 1, 2023
Clinical Assessment of SARS-CoV-2 Antibodies in Oral Fluids Following Infection and VaccinationChristopher D Heaney, Heidi Hempel, Kate L DeRosa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 26, 2025
Cancer and COVID-19: A review of immune insights and partnerships to inform public health strategyHeidi Hempel, Huijing Xue, Shin La Shu, et al.
Human Vaccines & Immunotherapeutics|January 27, 2026
Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccinationKathleen Kim, Carolina Porras, Aimee R Kreimer, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
Synthesis of novel cyclic NGR/RGD peptide analogs via on resin click chemistryBelhu B Metaferia, Matthew Rittler, Jinesh S Gheeya, et al.
The Journal of Pathology|December 18, 2020
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomesHeidi Hempel Sullivan, Janielle P Maynard, Christopher M Heaphy, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 21, 2015
Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple SitesKaren S Sfanos, Kirstie Canene-Adams, Heidi Hempel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer OutcomesHeidi Hempel Sullivan, Christopher M Heaphy, Ibrahim Kulac, et al.
Plos One|April 18, 2013
Development of peptide nucleic acid probes for detection of the HER2 oncogeneBelhu Metaferia, Jun S Wei, Young K Song, et al.
Pageof 1